Results 171 to 180 of about 14,468 (240)

Harm reduction practises for users of psychedelic drugs: a scoping review. [PDF]

Harm Reduct J
Dutton C, North E, Chun Tie Y, Oliva J, Skeffington P.   +4 more
europepmc   +1 more source

Learning from boundlessness: epistemic shifts towards a holistic worldview following psychedelic experiences. [PDF]

Npj Ment Health Res
Argyri EK, Fraser F, Schilling S, Frick A, Robinson OC, Roseman L, Morgan CJA.   +6 more
europepmc   +1 more source

Psychedelics Reverse the Polarity of Long-Term Synaptic Plasticity in Cortical-Projecting Claustrum Neurons. [PDF]

eNeuro
Anderson TL, Asadipooya A, Ortinski PI.
europepmc   +1 more source

Recalled childhood trauma and post-psychedelic trajectories of change in a mixed-methods study. [PDF]

Sci Rep
Simon G, Tadmor N, Skragge M, Evans J, Robinson O.   +4 more
europepmc   +1 more source

The ABCs of psychedelics: a preclinical roadmap for drug discovery. [PDF]

Trends Pharmacol Sci
Kwan AC, Mantsch JR, McCorvy JD.
europepmc   +1 more source

v. 31, no. 11, November 20, 1970 [PDF]

, 1970

core   +1 more source

Vigilance state dissociation induced by 5-MeO-DMT in mice. [PDF]

Commun Biol
Bréant BJB, Prius Mengual J, Andrews A, Hoerder-Suabedissen A, Patel J, Bannerman DM, Sharp T, Vyazovskiy VV.   +7 more
europepmc   +1 more source

A Tragedy of Errors: The State of Psychedelic Research in the Treatment of Alcohol Use Disorder. [PDF]

Brain Sci
Srivastava AB, Gold MS.
europepmc   +1 more source

Psychedelics for major depression-From controlled research settings into broader clinical use. [PDF]

Cell Rep Med
Avram M, Borgwardt S.
europepmc   +1 more source

Associations between psychedelic use and adverse outcomes in substance use disorders: a real-world EHR-based cohort study. [PDF]

Front Psychiatry
Qeadan F, McCunn A, Tingey B, Thielking P.   +3 more
europepmc   +1 more source